Cancer Genetic Testing
Updated On Feb 25, 2022
This information is meant to be used for educational purposes to inform providers, patients, and genetic service delivery stakeholders about genetics policy topics. Sharing of information, resources, or policy statements is no way an endorsement of stated positions by NCC.
Cancer genetic tests can help people understand their risk of developing cancer. It can also help people with cancer determine the best ways of treating their cancer, as some treatments are better for those with certain genetic profiles.
The American Cancer Society has written a primer, “Understanding Genetic Testing for Cancer: Genetics, gene mutations, and cancer risk,” with more information. Their website can be accessed here.
Legislation and Regulation
There are no laws or regulations specific to cancer genetic tests. Genetic tests are regulated at a federal level by the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and the Federal Trade Commission (FTC). For more information on how tests can be evaluated, review the National Human Genome Research Institute (NHGRI) website page about genetic testing.
Additionally, some states place additional regulations on genetic tests. The National Human Genome Research Institute (NHGRI) has also cataloged individual state statutes and legislation, which can be accessed here.
Are you interested in learning what your state’s government or the federal government are currently proposing for either legislation or regulation? Check out Legislative/Tracking system for up-to-date information and subscribe to our Twitter channel to get the latest updates in your pocket.
Organizations working within the genetics community (national genetic organizations, advocacy organizations, etc.) have published positions on cancer genetic testing. Explore these position statements below.